Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

MDOUTLOOK: Highlights from the US Physician Practices for CTCL

759 views

Published on

Highlights from MDOUTLOOK\'s 2008 Semi-Annual survey on the US Physician Practices for the management of Cutaneous T cell Lymphoma (CTCL)

Published in: Health & Medicine, Business
  • Be the first to comment

  • Be the first to like this

MDOUTLOOK: Highlights from the US Physician Practices for CTCL

  1. 1. CTCL Highlights from MDOUTLOOK’s Report: Current Physician Practices in the Management of Cutaneous T Cell Lymphoma MDOUTLOOK 2008 Semi-Annual Survey - Source: U.S. Physician Practices in the Management of Cutaneous T Cell Lymphoma Current Physician Practices in the Management of CTCL © MDOUTLOOK, LLC | Powered by The Arcas Group February 2009 | slide 1
  2. 2. CTCL Patients & Treaters CTCL Patient Flow and Stage Distribution Distribution of CTCL Patients by Stage Early Intermediate Advanced (limited) Advanced (extensive) 14% 41% 23% 22% Current Physician Practices in the Management of CTCL © MDOUTLOOK, LLC | Powered by The Arcas Group February 2009 | slide 2
  3. 3. CTCL Patients & Treaters Physicians Treating Each Stage of CTCL 15% 2% 12% Early Intermediate 8% 2% 3% 60% 0% 0% 2% 4% Advanced Advanced 2% 4% (extensive) (limited) Key Conclusions • Most physicians treat multiple stages of CTCL • Less than half treat ALL stages of disease Current Physician Practices in the Management of CTCL © MDOUTLOOK, LLC | Powered by The Arcas Group February 2009 | slide 3
  4. 4. CTCL NCCN Guidelines Conclusions about NCCN Guidelines on CTCL Treatment Practices • Fewer than half of physicians treating patients with CTCL are aware of recent revisions to NCCN guidelines concerning CTCL management – Dermatologists are the most aware of these revisions • If aware of the guideline revisions, the majority state their treatment practices are now in alignment with the current NCCN guidelines • Dermatologists are more likely to have changed treatment practices before the guideline revisions are published • Hematological oncologists are twice as likely to actually change their treatment practices due to guideline revisions Current Physician Practices in the Management of CTCL © MDOUTLOOK, LLC | Powered by The Arcas Group February 2009 | slide 4
  5. 5. CTCL The material in this report is restricted to personal educational use only. However, permission to use these materials for other educational purposes, including but not limited to distribution to your colleagues, staff, or patients, must first be obtained from MDOUTLOOK. PowerPoint slides of the information in this report for use in educational presentations may also be obtained upon request. Permission will be granted at our sole discretion. Contact: survey@mdoutlook.com 888.3OUTLOOK | 888.368.8566 (North America) +1.404.496.4136 (International) Current Physician Practices in the Management of CTCL © MDOUTLOOK, LLC | Powered by The Arcas Group ©February 2009 | slide 5 2008-2009 MDoutlook, LLC – All rights reserved

×